Europe Drug Delivery Systems Market 2027 By Route of Administration, Distribution Channel, and Application and Geography | The Insight Partners

The Europe drug delivery systems market is expected to reach US$ 610,320.4 Mn in 2027 from US$ 343,533.9 in 2018. The market is estimated to grow with a CAGR of 6.7% from 2019-2027.

Factors such as rising investments by pharmaceutical companies and medical device companies in research and development and rise of chronic disease conditions in Europe is expected to foster the growth of the Europe drug delivery systems market. On the other hand, regulatory recalls for drug delivery systems by European manufacturers are likely to create a negative impact on the market growth to an extent.

Products with the innovative technology with more effective benefits is a major requirement in the treatment for various chronic diseases. The advancement and development in the treatment are increasing in the last few years. As the prevalence of chronic diseases is increasing in the European region, the demand for more products with advancements is also boosting up. Hence, over the years, researchers have been carrying out research activities which have resulted in product innovations.

For instance, in July 2018, the Roche received CE mark for its innovative Accu-Chek Solo micropump system. The system is a small tube-free insulin delivery device that offers to their users the choice to bolus directly from the pump. The system is a fully functional handheld that comprises detach and re-attach function of pump without wasting insulin. The Accu-Chek Solo micropump integrates and the Roche’s digital health solutions contributing in a combination to provide more effective and personalized diabetes management to their users. The innovations in the drug delivery systems are thus likely to be a prevalent trend in the global drug delivery systems market over the coming years.

Germany Drug Delivery Systems Market Revenue and Forecasts to 2027 ( US$ Mn)

Get more information on this report : Request Free Sample PDF

EUROPE DRUG DELIVERY SYSTEMS– MARKET SEGMENTATION

By Route of Administration

• Oral
  • Solid Oral Drugs
  • Liquid Oral Drugs
  • Semi-solid Oral Drugs

• Transmucosal
  • Pulmonary Drug Delivery
    • In-metered Dose Inhalers
    • Dry Powder Inhalers
    • Nebulizers
  • Nasal Drug Delivery
    • Nasal Sprays
    • Nasal Drops
    • Nasal Gels
  • Buccal Drug Delivery
  • Sublingual Drug Delivery
  • Rectal Transmucosal Drug delivery
  • Vaginal Transmucosal Drug Delivery
• Injectable
  • Conventional Injection Devices
  • Self-Injection Devices
    • Needle Free Injectors
    • Pen Injectors
    • Wearable Injectors
• Topical
  • Semi-solid Topical Drug Delivery Formulations
  • Liquid Topical Drug Delivery Formulations
  • Solid Topical Drug Delivery Formulations
  • Transdermal Patches
  • Transdermal Gels
  • Others
• Implantable 
  • Active Implantable
  • Passive Implantable
• Ocular 
  • Eye Drops & Sprays
  • Gels & Ointments
  • Ocular Inserts
  • Drug Coated Contact Lenses

By Application

• Hospital & Clinics
• Home Care Settings
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Country

• Germany
• France
• UK      

Companies Mentioned

• BD
• Novo Nordisk A/S
• 3M
• Boston Scientific Corporation
• Bausch Health Companies Inc.
• Baxter International, Inc.
• Boehringer Ingelheim
• Novartis AG
• GlaxoSmithKline plc.
• Johnson & Johnson Services, Inc.